Obesity and oocyte quality: significant implications for ART and emerging mechanistic insights.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing clinical and animal literature without primary data or systematic search.
PubMed 34918035 · doi:10.1093/biolre/ioab228
What was done
This narrative review synthesizes clinical literature and animal model research to describe the multi-systemic impacts of obesity on female reproductive physiology, oocyte developmental competence, assisted reproductive technology (ART) outcomes, and pregnancy complications.
What was found
No numerical results or statistical effect sizes are reported in the abstract. Qualitatively, the review notes that obesity is linked to oxidative stress, lipotoxicity, pro-inflammatory pathways, insulin resistance, polycystic ovary syndrome, anovulation, and delayed conception. In ART, obesity correlates with lower live birth rates as well as higher rates of miscarriage, gestational diabetes, birth defects, stillbirth, and neonatal mortality. Animal models implicate ovarian lipotoxicity as a primary driver of reduced oocyte developmental competence.
Why it matters
It highlights how metabolic disturbances in obesity compromise cellular oocyte quality and downstream ART success, offering mechanistic context for clinical reproductive failures.
Limits
As a narrative review, it provides no new empirical data or quantitative meta-analysis. The relative contributions of oocyte quality versus uterine factors remain unresolved, and the potential compounding effects of ART procedures on pregnancy complications in obese women remain unstudied.
Cited by
- supports Metabolic function influences the quality of eggs, sperm, and embryos, as well as hormone signaling, conception rates, and IVF success rates.